Arvinas Inc (ARVN) is a biotechnology company listed on US.
Latest reported ARVN revenue for 2026-06-30 was $265.3M. Net income was $111.8M. ARVN currently screens at market cap $478.7M.
Use this ARVN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ARVN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ARVN SEC filings page. Lician reads the product cache first so this HTML stays unique to Arvinas Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ARVN income, balance, and cash tables.